Recent data from our group showed significantly increased MAPK activity, cell proliferation and migration in breast cancer cells stably expressing BRK-Y447F, and decreased migration in breast cancer cells depleted of BRK [28]. The gene discussed is PTK6; the disease is breast cancer.